nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—Carboplatin—ovarian cancer	0.539	1	CbGbCtD
Cysteamine—SST—vein—ovarian cancer	0.0789	0.459	CbGeAlD
Cysteamine—SST—myometrium—ovarian cancer	0.0155	0.0904	CbGeAlD
Cysteamine—SST—embryo—ovarian cancer	0.0149	0.0869	CbGeAlD
Cysteamine—SST—epithelium—ovarian cancer	0.0122	0.071	CbGeAlD
Cysteamine—SST—decidua—ovarian cancer	0.0115	0.067	CbGeAlD
Cysteamine—SST—endometrium—ovarian cancer	0.0109	0.0636	CbGeAlD
Cysteamine—SST—female reproductive system—ovarian cancer	0.00906	0.0527	CbGeAlD
Cysteamine—SST—lymph node—ovarian cancer	0.0053	0.0308	CbGeAlD
Cysteamine—MPO—Folate Metabolism—FOLR1—ovarian cancer	0.00495	0.0973	CbGpPWpGaD
Cysteamine—MPO—epithelium—ovarian cancer	0.00491	0.0286	CbGeAlD
Cysteamine—MPO—bone marrow—ovarian cancer	0.00344	0.02	CbGeAlD
Cysteamine—MPO—testis—ovarian cancer	0.00294	0.0171	CbGeAlD
Cysteamine—NPY2R—Circadian rythm related genes—TOP1—ovarian cancer	0.00257	0.0505	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—PPP1CC—ovarian cancer	0.00224	0.0441	CbGpPWpGaD
Cysteamine—MPO—lymph node—ovarian cancer	0.00213	0.0124	CbGeAlD
Cysteamine—NPY2R—Circadian rythm related genes—HNF1B—ovarian cancer	0.00195	0.0383	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—SOD1—ovarian cancer	0.00124	0.0244	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—SOD2—ovarian cancer	0.00112	0.0219	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—SOD1—ovarian cancer	0.00101	0.0198	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—SOD2—ovarian cancer	0.000907	0.0178	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—TYMS—ovarian cancer	0.000904	0.0178	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—SOD1—ovarian cancer	0.000801	0.0157	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL2—ovarian cancer	0.000751	0.0148	CbGpPWpGaD
Cysteamine—Urticaria—Chlorambucil—ovarian cancer	0.000738	0.00309	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HSD17B6—ovarian cancer	0.000736	0.0145	CbGpPWpGaD
Cysteamine—Abdominal pain—Chlorambucil—ovarian cancer	0.000735	0.00308	CcSEcCtD
Cysteamine—Body temperature increased—Chlorambucil—ovarian cancer	0.000735	0.00308	CcSEcCtD
Cysteamine—Renal failure—Paclitaxel—ovarian cancer	0.000734	0.00307	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000733	0.00307	CcSEcCtD
Cysteamine—Discomfort—Vinorelbine—ovarian cancer	0.000729	0.00306	CcSEcCtD
Cysteamine—Dyspepsia—Topotecan—ovarian cancer	0.000728	0.00305	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—SOD2—ovarian cancer	0.000721	0.0142	CbGpPWpGaD
Cysteamine—Decreased appetite—Topotecan—ovarian cancer	0.000719	0.00301	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000714	0.00299	CcSEcCtD
Cysteamine—Fatigue—Topotecan—ovarian cancer	0.000713	0.00299	CcSEcCtD
Cysteamine—Dyspepsia—Melphalan—ovarian cancer	0.000713	0.00299	CcSEcCtD
Cysteamine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000708	0.00297	CcSEcCtD
Cysteamine—Constipation—Topotecan—ovarian cancer	0.000707	0.00296	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Doxorubicin—ovarian cancer	0.000706	0.00296	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HSD17B6—ovarian cancer	0.000705	0.0139	CbGpPWpGaD
Cysteamine—Decreased appetite—Melphalan—ovarian cancer	0.000704	0.00295	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000699	0.00293	CcSEcCtD
Cysteamine—Fatigue—Melphalan—ovarian cancer	0.000698	0.00293	CcSEcCtD
Cysteamine—Nervous system disorder—Vinorelbine—ovarian cancer	0.000694	0.00291	CcSEcCtD
Cysteamine—Skin disorder—Vinorelbine—ovarian cancer	0.000687	0.00288	CcSEcCtD
Cysteamine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000685	0.00287	CcSEcCtD
Cysteamine—Feeling abnormal—Topotecan—ovarian cancer	0.000682	0.00286	CcSEcCtD
Cysteamine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000676	0.00284	CcSEcCtD
Cysteamine—Anorexia—Vinorelbine—ovarian cancer	0.000675	0.00283	CcSEcCtD
Cysteamine—Asthenia—Chlorambucil—ovarian cancer	0.000667	0.00279	CcSEcCtD
Cysteamine—Mental disability—Epirubicin—ovarian cancer	0.000662	0.00277	CcSEcCtD
Cysteamine—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000662	0.00277	CcSEcCtD
Cysteamine—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000658	0.00276	CcSEcCtD
Cysteamine—Urticaria—Topotecan—ovarian cancer	0.000657	0.00275	CcSEcCtD
Cysteamine—Urethral disorder—Paclitaxel—ovarian cancer	0.000657	0.00275	CcSEcCtD
Cysteamine—Abdominal pain—Topotecan—ovarian cancer	0.000654	0.00274	CcSEcCtD
Cysteamine—Body temperature increased—Topotecan—ovarian cancer	0.000654	0.00274	CcSEcCtD
Cysteamine—Urticaria—Melphalan—ovarian cancer	0.000643	0.0027	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.000637	0.00267	CcSEcCtD
Cysteamine—Diarrhoea—Chlorambucil—ovarian cancer	0.000636	0.00266	CcSEcCtD
Cysteamine—Hepatic function abnormal—Epirubicin—ovarian cancer	0.000634	0.00266	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—STAT3—ovarian cancer	0.000632	0.0124	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DLC1—ovarian cancer	0.000626	0.0123	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000624	0.0123	CbGpPWpGaD
Cysteamine—Renal failure—Docetaxel—ovarian cancer	0.000622	0.00261	CcSEcCtD
Cysteamine—Decreased appetite—Vinorelbine—ovarian cancer	0.000615	0.00258	CcSEcCtD
Cysteamine—Eye pain—Epirubicin—ovarian cancer	0.000613	0.00257	CcSEcCtD
Cysteamine—Mental disability—Doxorubicin—ovarian cancer	0.000612	0.00257	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000611	0.00256	CcSEcCtD
Cysteamine—Fatigue—Vinorelbine—ovarian cancer	0.00061	0.00256	CcSEcCtD
Cysteamine—Hypersensitivity—Topotecan—ovarian cancer	0.000609	0.00255	CcSEcCtD
Cysteamine—Constipation—Vinorelbine—ovarian cancer	0.000605	0.00254	CcSEcCtD
Cysteamine—Immune system disorder—Paclitaxel—ovarian cancer	0.000605	0.00254	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—DLC1—ovarian cancer	0.0006	0.0118	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000597	0.0117	CbGpPWpGaD
Cysteamine—Hypersensitivity—Melphalan—ovarian cancer	0.000597	0.0025	CcSEcCtD
Cysteamine—Asthenia—Topotecan—ovarian cancer	0.000594	0.00249	CcSEcCtD
Cysteamine—Vomiting—Chlorambucil—ovarian cancer	0.000591	0.00248	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.000589	0.00247	CcSEcCtD
Cysteamine—Mental disorder—Paclitaxel—ovarian cancer	0.000587	0.00246	CcSEcCtD
Cysteamine—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000586	0.00246	CcSEcCtD
Cysteamine—Erythema—Paclitaxel—ovarian cancer	0.000583	0.00244	CcSEcCtD
Cysteamine—Malnutrition—Paclitaxel—ovarian cancer	0.000583	0.00244	CcSEcCtD
Cysteamine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000583	0.00244	CcSEcCtD
Cysteamine—Asthenia—Melphalan—ovarian cancer	0.000581	0.00244	CcSEcCtD
Cysteamine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000579	0.00243	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000576	0.0113	CbGpPWpGaD
Cysteamine—Tension—Paclitaxel—ovarian cancer	0.000572	0.0024	CcSEcCtD
Cysteamine—Eye pain—Doxorubicin—ovarian cancer	0.000567	0.00238	CcSEcCtD
Cysteamine—Nervousness—Paclitaxel—ovarian cancer	0.000566	0.00237	CcSEcCtD
Cysteamine—Diarrhoea—Topotecan—ovarian cancer	0.000566	0.00237	CcSEcCtD
Cysteamine—Lethargy—Epirubicin—ovarian cancer	0.000565	0.00237	CcSEcCtD
Cysteamine—Urticaria—Vinorelbine—ovarian cancer	0.000562	0.00236	CcSEcCtD
Cysteamine—Urinary tract disorder—Docetaxel—ovarian cancer	0.000561	0.00235	CcSEcCtD
Cysteamine—Abdominal pain—Vinorelbine—ovarian cancer	0.000559	0.00234	CcSEcCtD
Cysteamine—Body temperature increased—Vinorelbine—ovarian cancer	0.000559	0.00234	CcSEcCtD
Cysteamine—Connective tissue disorder—Docetaxel—ovarian cancer	0.000558	0.00234	CcSEcCtD
Cysteamine—Urethral disorder—Docetaxel—ovarian cancer	0.000557	0.00233	CcSEcCtD
Cysteamine—Diarrhoea—Melphalan—ovarian cancer	0.000554	0.00232	CcSEcCtD
Cysteamine—Pain in extremity—Epirubicin—ovarian cancer	0.000554	0.00232	CcSEcCtD
Cysteamine—Nausea—Chlorambucil—ovarian cancer	0.000552	0.00231	CcSEcCtD
Cysteamine—Dizziness—Topotecan—ovarian cancer	0.000547	0.00229	CcSEcCtD
Cysteamine—Tremor—Paclitaxel—ovarian cancer	0.000546	0.00229	CcSEcCtD
Cysteamine—Affect lability—Epirubicin—ovarian cancer	0.000545	0.00228	CcSEcCtD
Cysteamine—Anaemia—Paclitaxel—ovarian cancer	0.000539	0.00226	CcSEcCtD
Cysteamine—Agitation—Paclitaxel—ovarian cancer	0.000536	0.00225	CcSEcCtD
Cysteamine—SST—Peptide ligand-binding receptors—CXCL8—ovarian cancer	0.000533	0.0105	CbGpPWpGaD
Cysteamine—Vomiting—Topotecan—ovarian cancer	0.000526	0.0022	CcSEcCtD
Cysteamine—Mood swings—Epirubicin—ovarian cancer	0.000524	0.0022	CcSEcCtD
Cysteamine—Lethargy—Doxorubicin—ovarian cancer	0.000523	0.00219	CcSEcCtD
Cysteamine—Leukopenia—Paclitaxel—ovarian cancer	0.000522	0.00219	CcSEcCtD
Cysteamine—Rash—Topotecan—ovarian cancer	0.000522	0.00219	CcSEcCtD
Cysteamine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000521	0.00219	CcSEcCtD
Cysteamine—Dermatitis—Topotecan—ovarian cancer	0.000521	0.00218	CcSEcCtD
Cysteamine—Ataxia—Epirubicin—ovarian cancer	0.000521	0.00218	CcSEcCtD
Cysteamine—Headache—Topotecan—ovarian cancer	0.000518	0.00217	CcSEcCtD
Cysteamine—Vomiting—Melphalan—ovarian cancer	0.000515	0.00216	CcSEcCtD
Cysteamine—Dehydration—Epirubicin—ovarian cancer	0.000515	0.00216	CcSEcCtD
Cysteamine—Immune system disorder—Docetaxel—ovarian cancer	0.000513	0.00215	CcSEcCtD
Cysteamine—Pain in extremity—Doxorubicin—ovarian cancer	0.000512	0.00215	CcSEcCtD
Cysteamine—Liver function test abnormal—Epirubicin—ovarian cancer	0.000511	0.00214	CcSEcCtD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCL8—ovarian cancer	0.000511	0.01	CbGpPWpGaD
Cysteamine—Rash—Melphalan—ovarian cancer	0.000511	0.00214	CcSEcCtD
Cysteamine—Dermatitis—Melphalan—ovarian cancer	0.00051	0.00214	CcSEcCtD
Cysteamine—SST—Signaling Pathways—BCL9—ovarian cancer	0.00051	0.01	CbGpPWpGaD
Cysteamine—Asthenia—Vinorelbine—ovarian cancer	0.000508	0.00213	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000507	0.00997	CbGpPWpGaD
Cysteamine—Convulsion—Paclitaxel—ovarian cancer	0.000505	0.00212	CcSEcCtD
Cysteamine—Affect lability—Doxorubicin—ovarian cancer	0.000504	0.00211	CcSEcCtD
Cysteamine—Hypertension—Paclitaxel—ovarian cancer	0.000504	0.00211	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—PIK3CA—ovarian cancer	0.000498	0.0098	CbGpPWpGaD
Cysteamine—Mental disorder—Docetaxel—ovarian cancer	0.000497	0.00209	CcSEcCtD
Cysteamine—Malnutrition—Docetaxel—ovarian cancer	0.000494	0.00207	CcSEcCtD
Cysteamine—Erythema—Docetaxel—ovarian cancer	0.000494	0.00207	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000493	0.00207	CcSEcCtD
Cysteamine—Nausea—Topotecan—ovarian cancer	0.000491	0.00206	CcSEcCtD
Cysteamine—Discomfort—Paclitaxel—ovarian cancer	0.000491	0.00206	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—BCL9—ovarian cancer	0.000489	0.00962	CbGpPWpGaD
Cysteamine—Mood swings—Doxorubicin—ovarian cancer	0.000485	0.00203	CcSEcCtD
Cysteamine—Diarrhoea—Vinorelbine—ovarian cancer	0.000484	0.00203	CcSEcCtD
Cysteamine—Ataxia—Doxorubicin—ovarian cancer	0.000482	0.00202	CcSEcCtD
Cysteamine—Nausea—Melphalan—ovarian cancer	0.000481	0.00202	CcSEcCtD
Cysteamine—Confusional state—Paclitaxel—ovarian cancer	0.00048	0.00201	CcSEcCtD
Cysteamine—Dehydration—Doxorubicin—ovarian cancer	0.000476	0.002	CcSEcCtD
Cysteamine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000476	0.00199	CcSEcCtD
Cysteamine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000473	0.00198	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL2—ovarian cancer	0.000472	0.00929	CbGpPWpGaD
Cysteamine—Dizziness—Vinorelbine—ovarian cancer	0.000468	0.00196	CcSEcCtD
Cysteamine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000467	0.00196	CcSEcCtD
Cysteamine—Skin disorder—Paclitaxel—ovarian cancer	0.000462	0.00194	CcSEcCtD
Cysteamine—Anaemia—Docetaxel—ovarian cancer	0.000457	0.00191	CcSEcCtD
Cysteamine—Anorexia—Paclitaxel—ovarian cancer	0.000454	0.0019	CcSEcCtD
Cysteamine—Vomiting—Vinorelbine—ovarian cancer	0.00045	0.00189	CcSEcCtD
Cysteamine—SST—G alpha (i) signalling events—CXCL8—ovarian cancer	0.00045	0.00884	CbGpPWpGaD
Cysteamine—Rash—Vinorelbine—ovarian cancer	0.000446	0.00187	CcSEcCtD
Cysteamine—Dermatitis—Vinorelbine—ovarian cancer	0.000446	0.00187	CcSEcCtD
Cysteamine—Headache—Vinorelbine—ovarian cancer	0.000443	0.00186	CcSEcCtD
Cysteamine—Leukopenia—Docetaxel—ovarian cancer	0.000442	0.00185	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—IL6—ovarian cancer	0.000441	0.00868	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—PTEN—ovarian cancer	0.000439	0.00864	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL8—ovarian cancer	0.000431	0.00848	CbGpPWpGaD
Cysteamine—Convulsion—Docetaxel—ovarian cancer	0.000428	0.0018	CcSEcCtD
Cysteamine—Hypertension—Docetaxel—ovarian cancer	0.000427	0.00179	CcSEcCtD
Cysteamine—Somnolence—Paclitaxel—ovarian cancer	0.000423	0.00177	CcSEcCtD
Cysteamine—Nausea—Vinorelbine—ovarian cancer	0.00042	0.00176	CcSEcCtD
Cysteamine—Renal failure—Epirubicin—ovarian cancer	0.000419	0.00176	CcSEcCtD
Cysteamine—Dyspepsia—Paclitaxel—ovarian cancer	0.000419	0.00176	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000418	0.00175	CcSEcCtD
Cysteamine—Decreased appetite—Paclitaxel—ovarian cancer	0.000414	0.00173	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000411	0.00172	CcSEcCtD
Cysteamine—Fatigue—Paclitaxel—ovarian cancer	0.00041	0.00172	CcSEcCtD
Cysteamine—Constipation—Paclitaxel—ovarian cancer	0.000407	0.00171	CcSEcCtD
Cysteamine—Confusional state—Docetaxel—ovarian cancer	0.000407	0.0017	CcSEcCtD
Cysteamine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000403	0.00169	CcSEcCtD
Cysteamine—SST—Signaling Pathways—DOK1—ovarian cancer	0.000403	0.00793	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CDKN1B—ovarian cancer	0.000398	0.00783	CbGpPWpGaD
Cysteamine—Nervous system disorder—Docetaxel—ovarian cancer	0.000396	0.00166	CcSEcCtD
Cysteamine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000392	0.00164	CcSEcCtD
Cysteamine—Skin disorder—Docetaxel—ovarian cancer	0.000392	0.00164	CcSEcCtD
Cysteamine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000389	0.00163	CcSEcCtD
Cysteamine—Renal failure—Doxorubicin—ovarian cancer	0.000388	0.00163	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—DOK1—ovarian cancer	0.000387	0.0076	CbGpPWpGaD
Cysteamine—Anorexia—Docetaxel—ovarian cancer	0.000385	0.00161	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—CCND1—ovarian cancer	0.00038	0.00747	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PPP1CC—ovarian cancer	0.000379	0.00746	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000378	0.00159	CcSEcCtD
Cysteamine—Urticaria—Paclitaxel—ovarian cancer	0.000378	0.00158	CcSEcCtD
Cysteamine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000376	0.00158	CcSEcCtD
Cysteamine—Abdominal pain—Paclitaxel—ovarian cancer	0.000376	0.00158	CcSEcCtD
Cysteamine—Body temperature increased—Paclitaxel—ovarian cancer	0.000376	0.00158	CcSEcCtD
Cysteamine—Urethral disorder—Epirubicin—ovarian cancer	0.000375	0.00157	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PPP1CC—ovarian cancer	0.000363	0.00715	CbGpPWpGaD
Cysteamine—Somnolence—Docetaxel—ovarian cancer	0.000359	0.0015	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000357	0.00703	CbGpPWpGaD
Cysteamine—Dyspepsia—Docetaxel—ovarian cancer	0.000355	0.00149	CcSEcCtD
Cysteamine—Decreased appetite—Docetaxel—ovarian cancer	0.000351	0.00147	CcSEcCtD
Cysteamine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000351	0.00147	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.00035	0.00689	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00035	0.00147	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000348	0.00146	CcSEcCtD
Cysteamine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000348	0.00146	CcSEcCtD
Cysteamine—Fatigue—Docetaxel—ovarian cancer	0.000348	0.00146	CcSEcCtD
Cysteamine—Urethral disorder—Doxorubicin—ovarian cancer	0.000347	0.00146	CcSEcCtD
Cysteamine—Immune system disorder—Epirubicin—ovarian cancer	0.000346	0.00145	CcSEcCtD
Cysteamine—Constipation—Docetaxel—ovarian cancer	0.000345	0.00145	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000343	0.00674	CbGpPWpGaD
Cysteamine—Asthenia—Paclitaxel—ovarian cancer	0.000342	0.00143	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—ovarian cancer	0.000341	0.00671	CbGpPWpGaD
Cysteamine—Mental disorder—Epirubicin—ovarian cancer	0.000336	0.00141	CcSEcCtD
Cysteamine—Malnutrition—Epirubicin—ovarian cancer	0.000333	0.0014	CcSEcCtD
Cysteamine—Erythema—Epirubicin—ovarian cancer	0.000333	0.0014	CcSEcCtD
Cysteamine—Feeling abnormal—Docetaxel—ovarian cancer	0.000332	0.00139	CcSEcCtD
Cysteamine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00033	0.00138	CcSEcCtD
Cysteamine—Tension—Epirubicin—ovarian cancer	0.000327	0.00137	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—NRAS—ovarian cancer	0.000327	0.00643	CbGpPWpGaD
Cysteamine—Diarrhoea—Paclitaxel—ovarian cancer	0.000326	0.00136	CcSEcCtD
Cysteamine—Nervousness—Epirubicin—ovarian cancer	0.000324	0.00136	CcSEcCtD
Cysteamine—Immune system disorder—Doxorubicin—ovarian cancer	0.00032	0.00134	CcSEcCtD
Cysteamine—Abdominal pain—Docetaxel—ovarian cancer	0.000319	0.00134	CcSEcCtD
Cysteamine—Body temperature increased—Docetaxel—ovarian cancer	0.000319	0.00134	CcSEcCtD
Cysteamine—Dizziness—Paclitaxel—ovarian cancer	0.000315	0.00132	CcSEcCtD
Cysteamine—Mental disorder—Doxorubicin—ovarian cancer	0.00031	0.0013	CcSEcCtD
Cysteamine—Malnutrition—Doxorubicin—ovarian cancer	0.000309	0.00129	CcSEcCtD
Cysteamine—Erythema—Doxorubicin—ovarian cancer	0.000309	0.00129	CcSEcCtD
Cysteamine—Anaemia—Epirubicin—ovarian cancer	0.000308	0.00129	CcSEcCtD
Cysteamine—Agitation—Epirubicin—ovarian cancer	0.000306	0.00128	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—MYC—ovarian cancer	0.000305	0.00599	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TP53—ovarian cancer	0.000303	0.00597	CbGpPWpGaD
Cysteamine—Tension—Doxorubicin—ovarian cancer	0.000303	0.00127	CcSEcCtD
Cysteamine—Vomiting—Paclitaxel—ovarian cancer	0.000303	0.00127	CcSEcCtD
Cysteamine—Rash—Paclitaxel—ovarian cancer	0.0003	0.00126	CcSEcCtD
Cysteamine—Dermatitis—Paclitaxel—ovarian cancer	0.0003	0.00126	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—ovarian cancer	0.0003	0.00589	CbGpPWpGaD
Cysteamine—Nervousness—Doxorubicin—ovarian cancer	0.0003	0.00126	CcSEcCtD
Cysteamine—Leukopenia—Epirubicin—ovarian cancer	0.000298	0.00125	CcSEcCtD
Cysteamine—Headache—Paclitaxel—ovarian cancer	0.000298	0.00125	CcSEcCtD
Cysteamine—Hypersensitivity—Docetaxel—ovarian cancer	0.000297	0.00125	CcSEcCtD
Cysteamine—Asthenia—Docetaxel—ovarian cancer	0.000289	0.00121	CcSEcCtD
Cysteamine—Convulsion—Epirubicin—ovarian cancer	0.000289	0.00121	CcSEcCtD
Cysteamine—Hypertension—Epirubicin—ovarian cancer	0.000288	0.00121	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HDAC6—ovarian cancer	0.000287	0.00565	CbGpPWpGaD
Cysteamine—Anaemia—Doxorubicin—ovarian cancer	0.000285	0.0012	CcSEcCtD
Cysteamine—Agitation—Doxorubicin—ovarian cancer	0.000284	0.00119	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000283	0.00557	CbGpPWpGaD
Cysteamine—Nausea—Paclitaxel—ovarian cancer	0.000283	0.00118	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000282	0.00118	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—KRAS—ovarian cancer	0.000281	0.00553	CbGpPWpGaD
Cysteamine—Discomfort—Epirubicin—ovarian cancer	0.00028	0.00118	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL6—ovarian cancer	0.000278	0.00546	CbGpPWpGaD
Cysteamine—Leukopenia—Doxorubicin—ovarian cancer	0.000276	0.00116	CcSEcCtD
Cysteamine—Diarrhoea—Docetaxel—ovarian cancer	0.000276	0.00116	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HDAC6—ovarian cancer	0.000275	0.00542	CbGpPWpGaD
Cysteamine—Confusional state—Epirubicin—ovarian cancer	0.000274	0.00115	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—ovarian cancer	0.000274	0.0054	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL8—ovarian cancer	0.000272	0.00535	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000272	0.00114	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000272	0.00534	CbGpPWpGaD
Cysteamine—Convulsion—Doxorubicin—ovarian cancer	0.000267	0.00112	CcSEcCtD
Cysteamine—Nervous system disorder—Epirubicin—ovarian cancer	0.000267	0.00112	CcSEcCtD
Cysteamine—Dizziness—Docetaxel—ovarian cancer	0.000267	0.00112	CcSEcCtD
Cysteamine—Hypertension—Doxorubicin—ovarian cancer	0.000266	0.00112	CcSEcCtD
Cysteamine—Skin disorder—Epirubicin—ovarian cancer	0.000264	0.00111	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—CXCL8—ovarian cancer	0.000261	0.00513	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000261	0.00109	CcSEcCtD
Cysteamine—Discomfort—Doxorubicin—ovarian cancer	0.00026	0.00109	CcSEcCtD
Cysteamine—Anorexia—Epirubicin—ovarian cancer	0.000259	0.00109	CcSEcCtD
Cysteamine—Vomiting—Docetaxel—ovarian cancer	0.000257	0.00108	CcSEcCtD
Cysteamine—Rash—Docetaxel—ovarian cancer	0.000254	0.00107	CcSEcCtD
Cysteamine—SST—Signaling Pathways—YAP1—ovarian cancer	0.000254	0.005	CbGpPWpGaD
Cysteamine—Dermatitis—Docetaxel—ovarian cancer	0.000254	0.00107	CcSEcCtD
Cysteamine—Confusional state—Doxorubicin—ovarian cancer	0.000254	0.00106	CcSEcCtD
Cysteamine—Headache—Docetaxel—ovarian cancer	0.000253	0.00106	CcSEcCtD
Cysteamine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000252	0.00106	CcSEcCtD
Cysteamine—SST—Signaling Pathways—XIAP—ovarian cancer	0.000249	0.0049	CbGpPWpGaD
Cysteamine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000247	0.00103	CcSEcCtD
Cysteamine—Skin disorder—Doxorubicin—ovarian cancer	0.000245	0.00102	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—YAP1—ovarian cancer	0.000244	0.00479	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SMARCA4—ovarian cancer	0.000243	0.00477	CbGpPWpGaD
Cysteamine—Somnolence—Epirubicin—ovarian cancer	0.000242	0.00101	CcSEcCtD
Cysteamine—Anorexia—Doxorubicin—ovarian cancer	0.00024	0.00101	CcSEcCtD
Cysteamine—Nausea—Docetaxel—ovarian cancer	0.00024	0.001	CcSEcCtD
Cysteamine—Dyspepsia—Epirubicin—ovarian cancer	0.00024	0.001	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—ovarian cancer	0.000239	0.0047	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—XIAP—ovarian cancer	0.000239	0.0047	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EREG—ovarian cancer	0.000237	0.00466	CbGpPWpGaD
Cysteamine—Decreased appetite—Epirubicin—ovarian cancer	0.000237	0.000991	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000235	0.000985	CcSEcCtD
Cysteamine—Fatigue—Epirubicin—ovarian cancer	0.000235	0.000983	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—SMARCA4—ovarian cancer	0.000233	0.00458	CbGpPWpGaD
Cysteamine—Constipation—Epirubicin—ovarian cancer	0.000233	0.000975	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—EREG—ovarian cancer	0.000227	0.00447	CbGpPWpGaD
Cysteamine—Feeling abnormal—Epirubicin—ovarian cancer	0.000224	0.00094	CcSEcCtD
Cysteamine—Somnolence—Doxorubicin—ovarian cancer	0.000224	0.000938	CcSEcCtD
Cysteamine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000223	0.000933	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PGR—ovarian cancer	0.000222	0.00437	CbGpPWpGaD
Cysteamine—Dyspepsia—Doxorubicin—ovarian cancer	0.000222	0.000929	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—ovarian cancer	0.000221	0.00434	CbGpPWpGaD
Cysteamine—Decreased appetite—Doxorubicin—ovarian cancer	0.000219	0.000917	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000217	0.000911	CcSEcCtD
Cysteamine—Fatigue—Doxorubicin—ovarian cancer	0.000217	0.00091	CcSEcCtD
Cysteamine—Urticaria—Epirubicin—ovarian cancer	0.000216	0.000906	CcSEcCtD
Cysteamine—Constipation—Doxorubicin—ovarian cancer	0.000215	0.000902	CcSEcCtD
Cysteamine—Body temperature increased—Epirubicin—ovarian cancer	0.000215	0.000902	CcSEcCtD
Cysteamine—Abdominal pain—Epirubicin—ovarian cancer	0.000215	0.000902	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PGR—ovarian cancer	0.000213	0.00419	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000209	0.00411	CbGpPWpGaD
Cysteamine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000207	0.00087	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PARP1—ovarian cancer	0.000206	0.00406	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000206	0.000863	CcSEcCtD
Cysteamine—Hypersensitivity—Epirubicin—ovarian cancer	0.0002	0.00084	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CG—ovarian cancer	0.0002	0.00394	CbGpPWpGaD
Cysteamine—Urticaria—Doxorubicin—ovarian cancer	0.0002	0.000838	CcSEcCtD
Cysteamine—Body temperature increased—Doxorubicin—ovarian cancer	0.000199	0.000834	CcSEcCtD
Cysteamine—Abdominal pain—Doxorubicin—ovarian cancer	0.000199	0.000834	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PARP1—ovarian cancer	0.000198	0.00389	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6ST—ovarian cancer	0.000197	0.00388	CbGpPWpGaD
Cysteamine—Asthenia—Epirubicin—ovarian cancer	0.000195	0.000818	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PIK3CG—ovarian cancer	0.00019	0.00373	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6ST—ovarian cancer	0.000189	0.00372	CbGpPWpGaD
Cysteamine—Diarrhoea—Epirubicin—ovarian cancer	0.000186	0.00078	CcSEcCtD
Cysteamine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000186	0.000777	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000184	0.00361	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CG—ovarian cancer	0.000182	0.00358	CbGpPWpGaD
Cysteamine—Asthenia—Doxorubicin—ovarian cancer	0.000181	0.000757	CcSEcCtD
Cysteamine—Dizziness—Epirubicin—ovarian cancer	0.00018	0.000754	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000176	0.00346	CbGpPWpGaD
Cysteamine—Vomiting—Epirubicin—ovarian cancer	0.000173	0.000725	CcSEcCtD
Cysteamine—Diarrhoea—Doxorubicin—ovarian cancer	0.000172	0.000722	CcSEcCtD
Cysteamine—Rash—Epirubicin—ovarian cancer	0.000172	0.000719	CcSEcCtD
Cysteamine—Dermatitis—Epirubicin—ovarian cancer	0.000171	0.000718	CcSEcCtD
Cysteamine—Headache—Epirubicin—ovarian cancer	0.00017	0.000714	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PPP2R1A—ovarian cancer	0.000167	0.00329	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CD—ovarian cancer	0.000167	0.00328	CbGpPWpGaD
Cysteamine—Dizziness—Doxorubicin—ovarian cancer	0.000167	0.000698	CcSEcCtD
Cysteamine—Nausea—Epirubicin—ovarian cancer	0.000162	0.000677	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PPP2R1A—ovarian cancer	0.000161	0.00316	CbGpPWpGaD
Cysteamine—Vomiting—Doxorubicin—ovarian cancer	0.00016	0.000671	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PIK3CB—ovarian cancer	0.00016	0.00315	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CD—ovarian cancer	0.00016	0.00314	CbGpPWpGaD
Cysteamine—Rash—Doxorubicin—ovarian cancer	0.000159	0.000665	CcSEcCtD
Cysteamine—Dermatitis—Doxorubicin—ovarian cancer	0.000159	0.000665	CcSEcCtD
Cysteamine—Headache—Doxorubicin—ovarian cancer	0.000158	0.000661	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CXCL8—ovarian cancer	0.000154	0.00302	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000153	0.00302	CbGpPWpGaD
Cysteamine—Nausea—Doxorubicin—ovarian cancer	0.00015	0.000627	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL8—ovarian cancer	0.000147	0.0029	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—IL2—ovarian cancer	0.000147	0.00289	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CB—ovarian cancer	0.000145	0.00286	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—ovarian cancer	0.000141	0.00277	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL8—ovarian cancer	0.00014	0.00275	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CB—ovarian cancer	0.000139	0.00274	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCL8—ovarian cancer	0.000134	0.00263	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL2—ovarian cancer	0.000133	0.00263	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TERT—ovarian cancer	0.000133	0.00262	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL2—ovarian cancer	0.000128	0.00252	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TERT—ovarian cancer	0.000128	0.00251	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CAV1—ovarian cancer	0.000123	0.00242	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ESR1—ovarian cancer	0.000119	0.00233	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CAV1—ovarian cancer	0.000118	0.00232	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6ST—ovarian cancer	0.000117	0.00229	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ESR1—ovarian cancer	0.000114	0.00224	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CG—ovarian cancer	0.000112	0.0022	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APC—ovarian cancer	0.000112	0.0022	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—NRAS—ovarian cancer	0.000112	0.0022	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6ST—ovarian cancer	0.000112	0.0022	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CG—ovarian cancer	0.000107	0.00211	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APC—ovarian cancer	0.000107	0.00211	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NRAS—ovarian cancer	0.000107	0.00211	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK3—ovarian cancer	0.000107	0.00211	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK3—ovarian cancer	0.000103	0.00202	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK1—ovarian cancer	0.000102	0.00201	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EGFR—ovarian cancer	0.000102	0.00201	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CD—ovarian cancer	9.85e-05	0.00194	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK1—ovarian cancer	9.79e-05	0.00193	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—ovarian cancer	9.79e-05	0.00192	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CA—ovarian cancer	9.76e-05	0.00192	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KRAS—ovarian cancer	9.64e-05	0.0019	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CD—ovarian cancer	9.44e-05	0.00186	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CA—ovarian cancer	9.35e-05	0.00184	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—KRAS—ovarian cancer	9.25e-05	0.00182	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CA—ovarian cancer	8.86e-05	0.00174	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ERBB2—ovarian cancer	8.7e-05	0.00171	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CB—ovarian cancer	8.59e-05	0.00169	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MTOR—ovarian cancer	8.59e-05	0.00169	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CA—ovarian cancer	8.49e-05	0.00167	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ERBB2—ovarian cancer	8.34e-05	0.00164	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL8—ovarian cancer	8.25e-05	0.00162	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MTOR—ovarian cancer	8.23e-05	0.00162	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CB—ovarian cancer	8.23e-05	0.00162	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRAS—ovarian cancer	8.2e-05	0.00161	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1B—ovarian cancer	8.06e-05	0.00158	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT1—ovarian cancer	7.97e-05	0.00157	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL8—ovarian cancer	7.91e-05	0.00156	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASP3—ovarian cancer	7.9e-05	0.00155	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—ovarian cancer	7.89e-05	0.00155	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—ovarian cancer	7.86e-05	0.00155	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—ovarian cancer	7.85e-05	0.00154	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1B—ovarian cancer	7.73e-05	0.00152	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCND1—ovarian cancer	7.69e-05	0.00151	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—ovarian cancer	7.64e-05	0.0015	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CTNNB1—ovarian cancer	7.61e-05	0.0015	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—ovarian cancer	7.57e-05	0.00149	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—ovarian cancer	7.56e-05	0.00149	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—ovarian cancer	7.52e-05	0.00148	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—ovarian cancer	7.46e-05	0.00147	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTEN—ovarian cancer	7.42e-05	0.00146	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCND1—ovarian cancer	7.37e-05	0.00145	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CTNNB1—ovarian cancer	7.3e-05	0.00144	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—ovarian cancer	7.24e-05	0.00142	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—ovarian cancer	7.16e-05	0.00141	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTEN—ovarian cancer	7.11e-05	0.0014	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—ovarian cancer	6.94e-05	0.00136	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—ovarian cancer	6.7e-05	0.00132	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT3—ovarian cancer	6.64e-05	0.00131	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NRAS—ovarian cancer	6.62e-05	0.0013	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—ovarian cancer	6.42e-05	0.00126	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT3—ovarian cancer	6.36e-05	0.00125	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NRAS—ovarian cancer	6.35e-05	0.00125	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK3—ovarian cancer	6.34e-05	0.00125	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—ovarian cancer	6.17e-05	0.00121	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK3—ovarian cancer	6.08e-05	0.0012	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK1—ovarian cancer	6.03e-05	0.00119	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—ovarian cancer	6.03e-05	0.00119	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—ovarian cancer	5.91e-05	0.00116	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK1—ovarian cancer	5.78e-05	0.00114	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—ovarian cancer	5.78e-05	0.00114	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KRAS—ovarian cancer	5.7e-05	0.00112	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KRAS—ovarian cancer	5.46e-05	0.00107	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CA—ovarian cancer	5.23e-05	0.00103	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—ovarian cancer	5.06e-05	0.000996	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CA—ovarian cancer	5.02e-05	0.000987	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—ovarian cancer	4.85e-05	0.000955	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—ovarian cancer	4.84e-05	0.000952	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—ovarian cancer	4.64e-05	0.000913	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—ovarian cancer	4.63e-05	0.000912	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—ovarian cancer	4.44e-05	0.000874	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—ovarian cancer	4.28e-05	0.000841	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—ovarian cancer	4.1e-05	0.000806	CbGpPWpGaD
